This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of oral cavity and pharynx
CD2_INSITU_OROPHARYNX
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditions
|
519386 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
55 |
4. Check minimum number of eventsNone |
55 |
5. Include endpointsNone |
55 |
6. Filter based on genotype QC (FinnGen only) |
53 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- D00
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of oral cavity and pharynx
based on the number of shared cases.
Similar with more cases:
- Neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 53 | 19 | 34 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.02 |
| Median age at first event (years) | 64.38 | 70.30 | 61.07 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 55
- Matched controls
- 550
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
256.2
28.7
27
*
D00.06
ICD-10 Finland
Cancer in situ in another part of the tongue
+∞
20.0
18
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
239.9
17.6
17
*
EJB10
NOMESCO Finland
Excision of tumor or other lesion of apex or body of tongue
86.9
17.0
18
*
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
43.9
13.5
16
5
SAA03
NOMESCO Finland
Extended examination of mouth
7.6
12.6
37
117
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
28.7
11.4
15
7
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
75.1
11.1
12
*
EKA10
NOMESCO Finland
iopsy of buccal mucosa
30.5
10.9
14
6
EJB30
NOMESCO Finland
Excision of tumor or other lesion of floor of the mouth
134.6
10.8
11
*
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
+∞
10.8
10
*
D00.04
ICD-10 Finland
In situ cancer of the floor of the mouth
+∞
10.8
10
*
ECA20
NOMESCO Finland
Biopsy of gingiva
119.8
9.7
10
*
D00.01
ICD-10 Finland
In situ cancer of the mucous membrane of the cheek
+∞
9.6
9
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
9.5
9.3
20
31
WZC00
NOMESCO Finland
Treatment plan or consultation
5.5
9.1
33
118
K13.78
ICD-10 Finland
Other change in the oral mucosa
25.0
8.9
12
6
EP1AE
NOMESCO Finland
Neck ultrasound examination
11.4
8.6
16
19
JDB10
NOMESCO Finland
Percutaneous gastrostomy
52.8
8.0
9
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
29.9
7.9
10
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
92.0
7.6
8
*
SBA00
NOMESCO Finland
Microbiological examinations
19.2
7.6
11
7
D00.05
ICD-10 Finland
In situ cancer of the pharyngeal part of the tongue
+∞
7.4
7
*
GBB00
NOMESCO Finland
Tracheostomy
35.1
7.4
9
*
SXA10
NOMESCO Finland
Oral mucosal sampling
45.8
7.0
8
*
EKB00
NOMESCO Finland
Excision of tumour or other lesion of cheek
45.8
7.0
8
*
K13.29
ICD-10 Finland
Indefinite leukoplakia
45.8
7.0
8
*
K13.20
ICD-10 Finland
Idiopathic leukoplakia
78.6
6.6
7
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
78.6
6.6
7
*
EHA10
NOMESCO Finland
Biopsy of palate
78.6
6.6
7
*
A07AA02
ATC
nystatin; oral
10.6
6.5
12
14
130
Kela drug reimbursment
Malignant tumour
6.5
6.4
17
35
WX402
NOMESCO Finland
General anaesthesia
4.8
6.4
19
55
8070/3-C02.1
ICD-O-3
Squamous cell carcinoma, NOS, of border of tongue
+∞
6.4
6
*
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
+∞
6.4
6
*
WX110
NOMESCO Finland
Infiltration anesthesia
5.3
6.2
46
270
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
25
90
4.26
6.38
2.8
2.5
—
—
—
0
0
36
177
3.99
5.75
3.6
2.5
—
—
—
0
0
6
6
11.01
3.58
1.3
1.3
—
—
—
0
0
11
33
3.90
3.02
2.0
1.4
—
—
—
0
0
34
217
2.48
2.66
10.1
5.7
11.91
10.40
umol/l
0.36
34
205
16
72
2.72
2.58
2.0
2.3
0.26
0.84
e6/l
—
10
40
14
59
2.84
2.54
7.1
7.2
102.50
103.97
mmol/l
0.31
14
59
15
67
2.70
2.44
4.1
5.8
0.92
1.01
mmol/l
0.93
15
61
27
162
2.31
2.35
2.3
1.9
99.21
90.90
pmol/l
0.44
14
79
25
146
2.31
2.31
2.6
2.2
83.53
74.91
nmol/l
0.65
19
127
15
72
2.49
2.10
2.1
1.9
—
—
—
0
0
11
49
2.56
1.77
1.4
1.6
—
—
—
0
0
7
25
3.05
1.71
1.9
1.7
—
—
—
0
0
12
57
2.41
1.70
13.3
10.9
—
—
—
0
0
20
123
1.98
1.52
2.6
2.9
0.36
0.25
e6/l
0.19
14
86
7
28
2.71
1.51
2.1
2.7
1.93
1.41
%
—
7
28
8
37
2.36
1.28
2.5
2.1
398.75
346.71
nmol/l
—
8
31
10
51
2.17
1.20
1.4
1.7
—
—
—
0
0
9
50
1.95
1.03
1.3
1.3
—
—
—
0
0
6
27
2.37
0.97
2.2
2.8
25.72
24.27
mmol/l
—
6
27
6
29
2.20
0.92
2.5
2.7
47.48
53.16
%
—
6
29
6
29
2.20
0.92
1.5
1.3
—
—
—
0
0
6
30
2.12
0.90
12.7
5.9
24.28
25.15
mmol/l
—
6
30
20
142
1.64
0.89
3.7
3.0
38.05
29.93
u/l
0.53
20
132
47
421
1.80
0.76
29.6
15.3
37.53
21.29
mg/l
2.14
40
344
5
25
2.10
0.75
1.2
1.8
—
—
—
0
0
37
317
1.51
0.67
6.0
4.3
16.14
12.12
mm/h
0.91
37
288
31
257
1.47
0.65
2.8
2.8
—
—
—
0
0
21
162
1.48
0.63
3.2
3.0
—
—
—
0
0
0
15
0.00
0.42
0.0
1.1
—
0.00
—
0
15
0
16
0.00
0.42
0.0
1.4
—
1.81
—
0
11
23
196
1.30
0.35
4.1
4.6
14.94
31.54
ng/l
2.43
17
151
14
172
0.75
0.34
4.8
4.1
—
—
—
0
0
5
70
0.69
0.28
1.4
1.2
—
9.71
—
0
28
15
178
0.78
0.27
3.0
3.9
13.64
21.37
%
—
5
80
5
38
1.35
0.24
1.6
2.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
0.00
—
0
12
0
12
0.00
0.21
0.0
1.1
—
0.00
—
0
12
31
288
1.18
0.17
4.8
2.9
68.13
48.04
u/l
0.60
31
276
47
478
0.89
0.17
42.4
22.0
39.40
40.99
%
1.40
42
457
5
43
1.18
0.10
3.8
4.6
3.00
13.80
ug/l
—
5
37
38
369
1.10
0.06
30.8
18.2
15.65
15.03
%
0.23
38
362
45
459
0.89
0.04
33.9
17.4
75.76
84.16
umol/l
1.40
45
459
41
402
1.08
0.03
22.2
15.1
82.24
77.79
ml/min/173m2
0.68
36
326
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
156.94
—
0
7
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
14.80
—
0
5
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_OROPHARYNX – Carcinoma in situ of oral cavity and pharynx
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).